Survey of U.S. Living Kidney Donation and Transplant Practices in the COVID-19 Era

Autor: Didier A. Mandelbrot, Meera N. Harhay, Michelle A. Josephson, Asif Sharfuddin, Mark A. Schnitzler, Krista L. Lentine, Roslyn B. Mannon, Bertram L. Kasiske, Vineeta Kumar, Luke S. Vest, Matthew Cooper, David A. Axelrod, Mona D. Doshi, Yasar Caliskan
Jazyk: angličtina
Rok vydání: 2020
Předmět:
KPD
kidney paired donation

medicine.medical_specialty
IRB
Institutional Review Board

Coronavirus disease 2019 (COVID-19)
030232 urology & nephrology
Telehealth
030204 cardiovascular system & hematology
DDKT
deceased donor kidney transplantation

LDKT
living donor kidney transplantation

Article
03 medical and health sciences
0302 clinical medicine
PCR
polymerase chain reaction

Pandemic
medicine
Cumulative incidence
CMS
Centers for Medicare and Medicaid Services

OPTN
Organ Procurement and Transplantation Network

Evaluation
Kidney transplantation
UNOS
United Network for Organ Sharing

Scientific Registry of Transplant Recipients
(SRTR)

business.industry
Living Kidney Donation
Follow-up
Kidney donation
COVID-19
AST
American Society of Transplantation

medicine.disease
Kidney Transplantation
Transplantation
ASTS
American Society of Transplant Surgeons

Nephrology
Family medicine
COVID-19
Coronavirus Disease 2019

Screening
Professional association
business
PPE
personal protective equipment

COP
Community of Practice
Zdroj: Kidney International Reports
ISSN: 2468-0249
Popis: The scope of the impact of the coronavirus disease 2019 (COVID-19) pandemic on living donor kidney transplantation (LDKT) practices is not well defined.We surveyed US transplant programs to assess practices, strategies, and barriers to living LDKT during the COVID-19 pandemic. After institutional review board approval, the survey was distributed from 9 May 2020 to 30 May 2020 by e-mail and postings to professional society list-servs. Responses were stratified based on state COVID-19 cumulative incidence levels.Staff at 118 unique centers responded, representing 61% of US living donor recovery programs and 75% of LKDT volume in the prepandemic year. Overall, 66% reported that LDKT surgery was on hold (81% in "high" vs. 49% in "low" COVID-19 cumulative incidence states). A total of 36% reported that evaluation of new donor candidates had paused, 27% reported that evaluations were very much decreased (0% to 25% typical), and 23% reported that evaluations were moderately decreased (25% to 50% typical). Barriers to LDKT surgery included program concerns for donor (85%) and recipient (75%) safety, patient concerns (56%), elective case restrictions (47%), and hospital administrative restrictions (48%). Programs with higher local COVID-19 cumulative incidence reported more barriers related to staff and resource diversion. Most centers continuing donor evaluations used remote strategies (video, 82%; telephone, 43%). As LDKT resumes, all programs will screen for COVID-19, although timeframe and modalities will vary. Recommendations for presurgical self-quarantine are also variable.The COVID-19 pandemic has had broad impacts on LDKT practice. Ongoing research and consensus building are needed to reduce barriers, to guide optimal practices, and to support safe restoration of LDKT across centers.
Databáze: OpenAIRE